All posts by medical

BEYOND LOCAL: Sniffles and itchy eyes in winter? It could be allergies – ThoroldNews.com

Bad news, allergy sufferers winter wont necessarily give you a break.

There are what we call perennial allergens that never really go away, said Dr. Anne Ellis, professor and chair of the division of allergy and immunology at Queens University.

Things like house dust mites, which are microscopic spider-like insects that live in our mattress and pillow, certain moulds can live indoors in homes, and obviously if people have pets cats and dogs they usually allow them in the house and theyre not leaving, because its wintertime.

Mice also like to come inside during the winter, said Dr. Paul Keith, an associate professor in McMaster Universitys division of allergy and clinical immunology. These rodents can also be an allergy trigger for many people, he said, if they get into the house.

Part of the problem is that we spend more time indoors during the winter, Ellis said, which is not a great environment for allergy sufferers.

In winter, people usually keep their houses closed up and dont have air conditioners running or windows open which means allergens can build up in the closed area, she said. Heaters can make the air drier, which is also irritating for some.

These arent the same as seasonal allergies though.

Theres no pollen in the air right now, she said. Its tempting to think that theres something in the air when you have these intermittent mild melts. But usually whats happening there is that people who have allergies, they have hypersensitive airways anyway and so any changes in climate can trigger irritant-type symptoms in the nose.

Winter is also cold season, she said, and it can be tricky to tell the difference between an allergy and an infection.

Allergies typically would not cause you to have a fever, and you wouldnt get a sore throat.

Swollen lymph nodes and a general icky, not-great feeling are also probably a cold of some kind, not an allergy, she said.

If you do have allergies, there are things you can do to help lessen your symptoms, starting with trying to eliminate the allergen in your home.

With pets, you want to try to keep the pet out of the bedroom, so that [in] the room where you spend at least eight hours a day, youre not exposed to a higher level [of allergens], Keith said.

For dust mite allergy, we recommend covering the pillow and mattress to reduce your exposure, he said.

You should also change your sheets and pillowcases every week and wash them in hot water, Ellis said.

Similarly, Keith said, many people dont wash their winter coats very often, and these can also attract dust mites.

Air purifiers can make a difference, Ellis said, but they must be certified allergy-asthma friendly.

You may also want to try tackling your symptoms with medication. Saline nasal sprays can help wash allergens out of your nose, Keith said.

Pharmacies sell lots of very effective non-sedating antihistamines, Ellis said. She strongly recommends second-generation antihistamines, sold under brand names like Claritin and Allegra, over older antihistamines like diphenhydramine (Benadryl), because they have fewer side-effects and are more effective.

Nasal steroid sprays can also be effective, she said, though people need to be aware it can take a few days for the effect to kick in. You need to use it every day for at least a week to notice a significant improvement in your symptoms.

And, she said, if you find over-the-counter options dont work, you should consult a primary care provider or an allergist.

Allergy specialists love to see patients even with minor concerns, because we really like helping people for things that we know can be a burden to the patients who experience them.

Originally posted here:
BEYOND LOCAL: Sniffles and itchy eyes in winter? It could be allergies - ThoroldNews.com

The ‘Jekyll and Hyde’ of immune cells – Health Europa

These cells play a key protective role in immunity to infection however, if unregulated, they can also cause tissue damage in autoimmune disorders.

The research, published in theJournal of Experimental Medicine, should help us design more effective vaccines to prevent infections such as MRSA and may also assist help us develop of new therapies for autoimmune diseases, such as multiple sclerosis or rheumatoid arthritis.

The immune system functions to control infection, utilising various immune cells, such as T cells to respond to and control invading microbes. However, if these immune cells are not highly regulated, they can attack and damage body tissues, leading to the development of autoimmune diseases.

Molecules called T cell receptors (TCRs) allow T cells to recognise components of infectious agents with exquisite specificity. The TCRs enable T cells to respond to and eventually eliminate the infectious agent.

Professor Kingston Mills, Professor of Experimental Immunology, School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute, Dublin explained that: Until now scientists thought that there were two discrete populations of T cells, expressing either or TCRs. The s are the most common T cells in the body.

They play a key role in remembering prior infection or immunisation and thereby help protect us against re-infection and mediate vaccine-induced protective immunity. The s are more prevalent at mucosal surfaces, such as the lung or gut, and provide an immediate first line of defence against pathogens that invade through these routes.

We have discovered a new cell type that expresses both and TCRs. This rare population of chimeric or hybrid - T cells has properties of both and T cells. Importantly, they are normally highly activated and poised to act as first responders to control bacterial infection.

However, given this high level of activation, they are effectively Jekyll and Hyde cells because in certain contexts they can also precipitate autoimmune responses.

Using a model of Staphylococcus aureus infection, Mills and his team found that these cells are rapidly mobilised during infection and play a key role in quickly eliminating the microbes from the body.

By introducing these hybrid - T cells, it may represent a novel approach in the design of more effective vaccines against Staph aureus and other infectious diseases, while advancing our ability to control their response may yield additional therapeutic options.

Mills added: In a model of autoimmune disease, we found that the hybrid T cells can also trigger the inflammatory cascade that mediates tissue damage in autoimmunity. Therefore, approaches for inhibiting these highly activated immune cells in susceptible individuals may open up new approaches for the treatment of autoimmune diseases such as psoriasis and multiple sclerosis.

Read the rest here:
The 'Jekyll and Hyde' of immune cells - Health Europa

2020-2025 Global and Regional Immunology Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report – Monroe…

The global Immunology market report by HNY Research offers users a detailed overview of the market and all the main factors affecting the market. The study on global Immunology market, offers profound understandings about the Immunology market covering all the essential aspects like revenue growth, supply chain, sales, key players and regions. There is a target set in market that every marketing strategy has to reach. This report on Immunology focusses on different categories that define this market with a systematic approach that addresses the consumer base, researchers and market experts like the stakeholders. It also gives a clear perspective towards the competition and demand and supply chain.

Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4361436

Manufacturer Detail

By Market Players:AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Bionor Pharma, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics

By Application

By TypeImmuno Boosters, Immunosuppressants

The Immunology market report also offers some presentations and illustrations about the market that comprises pie charts, graphs, and charts which presents the percentage of the various strategies implemented by the service providers in the global Immunology market. This report on Immunology has been very well drafted to benefit anyone studying it. There are different marketing strategies that every marketer looks up to in order to ace the competition in the Global market. Some of the primary marketing strategies that is needed for every business to be successful are Passion, Focus, Watching the Data, Communicating the value To Your Customers, Your Understanding of Your Target Market. Every market research report follows a robust methodology to define its market value. By doing so, the Immunology research study by HNY Research offers collection of information and analysis for each facet of the Immunology market such as technology, regional markets, applications, and types.

Browse the complete report @ https://www.orbisresearch.com/reports/index/2020-2025-global-and-regional-immunology-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report

This study can benefit investors and business owners in many ways. It studies the business models, strategies, growth, innovations and every information about manufacturers that can help make business predictions and fetch good results. Making right business decisions is an undeniable measure that needs to be taken for market growth. Every market has a set of manufacturers, vendors and consumers that define that market and their every move and achievements becomes a subject of studying for market researchers and other stakeholders. One of the most important aspects focused in this study is the regional analysis. Region segmentation of markets helps in detailed analysis of the market in terms of business opportunities, revenue generation potential and future predictions of the market. For Immunology report, the important regions highlighted are North America, South America, Asia, Europe and Middle East. Another important aspect of every market research report by HNY Research is the study of the key players or manufacturers driving the market forward. The process helps to analyze the opponent thoroughly.

Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/4361436

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155Email ID: [emailprotected]

Continued here:
2020-2025 Global and Regional Immunology Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report - Monroe...

Italian Government to close all school and universities – Buzz.ie

Italian News Agency, ASNA, has reported today that following a meeting between the Prime Minister Guiseppe Conta and ministers at Palazzo Chigi today, the Italian government is set to close all schools and universities for two weeks.

Northern Italian schools, businesses and universities have been closed for a week now following the coronavirus outbreak resulting in towns in the North of the country going into quarantine.

There have been 2,500 confirmed cases of the virus in Northern Italy, with 79 confirmed deaths, making it the most affected area outside of China.

Professor Kingston Mills, an expert in immunology and the head of the centre for the study of immunology at Trinity College, Dublin, has also come out today to ask the questions of should flights still be running in and out of Italy given the severity of the outbreak. He said; "We need to look more seriously at means of curtailing travel to that region."

Mills, who spoke with RTE's Sean O'Rourke this morning on The Sean O'Rourke Show said he queried the information put out by the HSE saying that the virus could be contracted within 15 minutes of being in the company of someone who has the virus saying, "fifteen minutes is an arbitrary figure".

There has been no evidence so far in Ireland that shows local transmission of the virus, which is slowing the spread of Covid-19 in the country.

Ryanair have also confirmed there has been a notable drop in the number of flight bookings from the middle of March right into next month.

Want Buzz.ie news updates? Sign up to our newsletter!:

Here is the original post:
Italian Government to close all school and universities - Buzz.ie

Oakcrest School Advances to States in the Virginia Science Olympiad – Vienna Connection

Oakcrests entire Science Olympiad team. Photo contributed

Oakcrest School earned a spot in the Virginia Science Olympiad high school state tournament by finishing in fifth place at the regional competition held at the University of Mary Washington on Saturday, Feb. 8.

Oakcrest was the only all-girls school among the eleven in the high school competition, which included Thomas Jefferson High School for Science and Technology, Fairfax High School and McLean High School. With two teams in the high school division, Oakcrest took first place among the eleven high schools in the Anatomy and Physiology competition, and fourth in the coding-intensive Detector Building category.

Oakcrest was also the only all-girls school among the thirteen middle schools that competed in the regional tournament. With one team in the middle school division, Oakcrest placed tenth out of twenty teams.

Notable high school student achievements included:

Mackenzie M. (20): First place, Anatomy & Physiology

Rachel F. (22) and Faven K. (23): Second place, Gravity Vehicle

Sofia J. (21) and Hannah L. (21): Fourth place, Detector Building

Rachel F. (22) and Grace C. (22): Sixth place, Fossils

Notable middle school student achievements included:

Vivian K. (25) and Ashleigh Y. (25): Fourth place, Heredity

Megan B. (25) and Maddie M. (26): Sixth place, Density Lab

It was a wonderful team effort across the board. The girls represented Oakcrest very well! said Science Olympiad coach and Oakcrest science teacher Dr. Kat Hussmann.

This will be the second year in a row that Oakcrest sends students to the Virginia Science Olympiad State Tournament. In 2019, Oakcrest was the first ever all-girls team to compete in the state tournament and Dr. Hussmann received the Virginia Science Olympiad Coach of the Year award. States will take place on March 28 at the University of Virginia.

See more here:
Oakcrest School Advances to States in the Virginia Science Olympiad - Vienna Connection

Fast Talk, ep. 100: Polarized Training – past, present, and future – VeloNews

Dr. Seiler, aka the Jay-Z of physiology, talks about the inception of the polarized method.

Welcome to episode 100 with Dr. Stephen Seiler! We are so proud to have now brought 100 episodes of our passion for the bike to you. Thanks to all of you for coming along with us as weve interviewed some of the best physiologists, nutritionists, and athletes in professional cycling, and many of the most knowledgeable coaches in the world.

Today in episode 100, we get nearly two hours of Dr. Seiler, aka the Jay-Z of physiology. Our conversation is very natural, casual even, but there are so many moments of enlightenment and clarity.

Yes, Trevor wrote an outline for the show, as he always does. Thanks, Trevor. Then we proceeded to completely disregard it.

In many ways, it makes for a heck of a good show. We learn about the inception of the polarized method, from the creator himself. We discuss Dr. Seilers current research on the all-important aerobic threshold. And we jawthats my nod to his Texas rootsabout the future of sport science. Get ready for the wisdom to drop.

Are you following Dr. Seiler on Twitter? If not, you should. He frequently posts workout challenges, surveys, and his commentary on new scientific research and studies.

Now, sit back and grab your favorite beverage, or, better yet, find a nice long stretch of lonely road to listen in. Lets make you fast!

Check out all 100 Fast Talk Podcast episodes here.

More:
Fast Talk, ep. 100: Polarized Training - past, present, and future - VeloNews

Cooley Strengthens IP Litigation Team With DC Duo – Financial Post

Arriving from Finnegan, they bring powerful life sciences, ANDA litigation capabilities

WASHINGTON Cooley is growing its market-leading intellectual property litigation practice group with the addition of partners Sanya Sukduang and Jonathan Davies, who will be based in Washington, DC. Arriving from Finnegan, Henderson, Farabow, Garrett & Dunner, Sukduangs and Davies practices focus on life sciences with an emphasis on pharmaceuticals litigation, including HatchWaxman Abbreviated New Drug Application (ANDA) litigation.

Sanyas and Jonathans experience navigating complex ANDA cases adds significant depth to the life sciences component of our IP litigation practice and complements the work done by our patent counseling and life sciences partnering practice groups, said Stephen Smith, chair of Cooleys intellectual property litigation practice. Together, their experience will prove an invaluable asset to our clients, particularly the increasing number of them with later-stage products ripe for ANDA litigation.

Sukduang advises clients on patent litigation before federal district courts and the US Court of Appeals for the Federal Circuit, as well as all aspects of proceedings before the Patent Trial and Appeal Board. His work centers on litigating matters concerning ANDA challenges for brand drug manufacturers, diagnostic methods, biological products and medical devices. Sukduang also guides clients on an array of issues concerning biologics, including due diligence investigations and strategic patent portfolio planning. He formerly chaired Finnegans diversity and inclusion committee.

Davies practice centers around patent litigation, particularly on pharmaceutical and biotechnology cases, including HatchWaxman litigation related to ANDAs and biologics litigation under the Biologics Price Competition and Innovation Act. He has deep experience advising on all aspects of pretrial and trial federal district court practice, in addition to advising clients on infringement and validity opinions. Prior to his legal career, Davies completed graduate studies in human physiology and conducted doctoral and post-doctoral research in cellular and molecular biology and genetics.

We know firsthand how high stakes ANDA litigation is for the innovative companies we advise, said Sukduang. We are excited about the opportunities well be able to provide our clients with the support of Cooleys powerful IP litigation platform.

We look forward to delivering successful results for our clients as we team up with our new colleagues, said Davies. We are also impressed by Cooleys standout, collaborative culture and are eager to help build on the firms legacy as it continues to grow.

With a team of 60+ lawyers, Cooleys IP litigation practice is renowned for its ability to win bet-the-company competitor cases in which multibillion-dollar products, technologies and brands are at stake. The practice has unprecedented experience representing clients in tech and life sciences matters. Cooley boasts one of the most active patent litigation practices in the US, having handled 525+ patent cases and 70+ Federal Circuit patent appeals, the vast majority as the appellee, in the past five years.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,100+ lawyers across 16 offices in the United States, Asia and Europe.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200303005657/en/

Contacts

Andrea Orzehoski Cooley LLP aorzehoski@cooley.com +1 858 550 6259

Read more here:
Cooley Strengthens IP Litigation Team With DC Duo - Financial Post

First-Year Lab Experience Gave This Student the Confidence to Aim for a Ph.D. – UVA Today

A University of Virginia biomedical engineering student is trying to tackle the worlds No. 1 cause of death on a genetic level.

Rita Anane-Wae, from Ghana by way of Glendale, Arizona, and a third-year biomedical engineering student, is using a 2019 Harrison Undergraduate Research grant to seek a genetic solution to atherosclerosis, or the build-up of plaque in ones arteries, which impedes blood flow.

There are cells that will try to fix this problem by covering them and basically pushing the plaque down to allow blood flow, she said. These cells will try to reduce that plaque so that there is correct blood flow. In very serious cases, the plaque can harden and break off. Once it breaks, it can get lodged somewhere and cause a stroke or a heart attack.

Created through a gift from the late David A. Harrison III and his family, the Harrison Undergraduate Research Awards fund outstanding undergraduate research projects. Selected by a faculty review committee, awardees receive as much as $4,000 apiece to pursue their research interests, under the direction of a faculty mentor.

Anane-Wae started working in a laboratory run by Mete Civelek, an assistant professor of biomedical engineering, as a second-year student.

Civelek had already altered her life. Anane-Wae came to UVA to be a chemical engineer. She met Civelek when she signed up as a first-year student for a program that offered faculty mentoring.

At the time I was a chemical engineering major with an interest in biomedical engineering, Anane-Wae said. After talking with him, he was able to assuage my fears about biomedical engineering.

Biomedical engineering is a relatively new field and as such, I did not believe there were many jobs out there, and my parents were worried for the same reason, she said. Mete has a chemical engineering undergrad degree and a masters and Ph.D. in biomedical engineering, so he was the perfect person for me to talk to. He explained the two fields in a unique way, unlike what I had read and seen on YouTube.

Honestly, I love biomedical engineering. When I switched into biomedical engineering, literally in my first class, I though Oh, my God, this is home. I am learning about anatomy, physiology, genes and cells, and it is still all really exciting for me.

Civelek also suggested Anane-Wae participate in the research trip to Uganda through the UVA Minority Health & Health Disparities International Research Training program to perform research on congestive heart failure. While in Uganda, Anane-Wae made rounds with a doctor at a local hospital and met a 17-year-old girl suffering from congestive heart failure.

Her legs were all swollen, Anane-Wae said. She had edema and her stomach was filled with fluid. I was looking at her and thinking, This girl cant lay down because of all the swelling and she cant even be at rest. And I was thinking, She is about my age and I am fortunate enough to be traveling the world and she is here stuck in this hospital bed.

Her encounter with the girl became part inspiration to her and part reminder that congestive heart failure is not just for older patients.

I have a hard time accepting what I am capable of doing, Anane-Wae said. Being here, being in Uganda, working in the lab, it has taught me that I am basically capable of making change. I know what I am supposed to be doing with my time and my future and I know that doing it makes me happy and will make other people better.

In her lab work, Anane-Wae studies a specific gene melanoma inhibitor activity 3, or MIA3 that affects smooth muscle cells.

Smooth muscle cells are able to basically cover the plaque in that disease state, Anane-Wae said. We are running experiments to see how us modulating MIA3 affects the disease.

She said she and members of the research team in the lab also performed experiments knocking out the MIA3 gene from the cells, which led to a more serious disease state.

I think experiments like these are really important because we are not yet at the stage where we can do gene therapy on a person, Anane-Wae said. If you knock out specific genes, it will affect things that we dont understand yet.

Anane-Wae is working on a small section of a large field, but she thinks there is promise in the work she is doing.

The genome-wide association studies show that 161 different genes so far have been associated with coronary artery disease, she said. And we are studying just one. There is so much further that we have to go.

The path is really long, but we are trying to understand the mechanism by which one gene affects the disease and if we actually figure out that mechanism, we can try to apply it to the other genes and maybe understand the bigger picture.

Research can lead her down many blind alleys, which she understands. Anane-Wae is also very conscious of the law of unintended consequences, and how something that solves one problem can create other problems in the process.

We can say that about everything, she said. I think that is the way with all new development. You fix problems and new ones will arise, and then you fix those, too. So we can only do so much. But I think what I have learned is that I have found something about which I am passionate. I have found something that I enjoy and here at UVA, I have found a community of people who will help me develop my skills.

Included in that community, Anane-Wae cited Civelek and Redouane Aherrahrou, an American Heart Association Postdoctoral Fellow with whom she works.

Aherrahrou has known Anane-Wae since she joined the lab in 2018. When she first joined our lab, Rita knew only the fundamental lab skills and methods, he said. After a short amount of training, she learned rapidly and became very familiar with the cell culture techniques and appropriate lab handling. She performed the experiments independently. Her interactions with other lab members are both professional and friendly.

He described Anane-Wae as a diligent researcher, a gifted student, an inspiring person, and enjoyable to be around.

She has a great personality, is open to guidance and responds well to criticism, he said. She wants to apply to Ph.D. programs after she graduates, and I predict a great future in her career as a research scientist.

Civelek said he enjoys having Anane-Wae as part of his team.

She is hard-working, curious and eager to make a scientific impact, he said. I can see the joy in her face when she learns something new. She gets along well with everyone in the lab and is a role model to those who are junior to her. She has a bright future and I am very proud of her accomplishments.

Civelek said Anane-Wae was recently awarded a German Academic Exchange Research Internship in Science and Engineering, which is presented to only 300 students from the U.S. and Canada.

Redouane and Mete both have high standards for me and motivate me to do my very best, Anane-Wae said. They have instilled a confidence in me that I did not have prior to joining the lab, and they continuously push me to achieve great things. I am so fortunate to have these two individuals as mentors, in addition to all of the other members in the laboratory.

A Blue Ridge Scholarship recipient, Anane-Wae is member of the National Society of Black Engineers and the Society of Women Engineers. She also has received a Hugh Bache Scholarship.

Anane-Wae said she is looking at doing big things, such as gene therapy, but realizes that she has to take small steps at first, and that her friends in the lab will help her out when things go wrong.

She has also learned that research is a team effort, not a solo pursuit.

You cant do research by yourself, she said. You wont be able to get anything done. You will have to depend on other people and you have to be able to share what you have learned. You wont get anything done in any amount of time if you dont trust other people and work together.

Continued here:
First-Year Lab Experience Gave This Student the Confidence to Aim for a Ph.D. - UVA Today

Our Education: SIUEs Fernandez del Valle committed to optimizing womens health – Alton Telegraph

SIUEs Maria Fernandez del Valle, PhD, assistant professor of exercise physiology in the School of Education, Health and Human Behaviors Department of Applied Health.

SIUEs Maria Fernandez del Valle, PhD, assistant professor of exercise physiology in the School of Education, Health and Human Behaviors Department of Applied Health.

SIUEs Maria Fernandez del Valle, PhD, assistant professor of exercise physiology in the School of Education, Health and Human Behaviors Department of Applied Health.

SIUEs Maria Fernandez del Valle, PhD, assistant professor of exercise physiology in the School of Education, Health and Human Behaviors Department of Applied Health.

Our Education: SIUEs Fernandez del Valle committed to optimizing womens health

EDWARDSVILLE Southern Illinois University Edwardsvilles Maria Fernandez del Valle, PhD, is researching optimizing womens health.

The assistant professor of exercise physiology in the School of Education, Health and Human Behaviors Department of Applied Health is a prime example of a teacher-scholar who has established multi-disciplinary collaborations and consistently involves students to pursue high impact research.

My research focuses on improving exercise prescription through different lines of study to help individuals optimize their health, she said. Currently, were targeting women, and conducting research on cardiac fat and function to determine how different modes of exercise can help us improve both.

I want to improve the way we prescribe exercise, she said. We need a larger sample size to clearly see data trends, but early indications show that we can have a high impact on cardiac fat around the heart with resistance training alone. The implication then would be that obese women should do resistance training to target more internal fat rather than the fat you see on the outside. Because, internal fat is what I linked to the development of metabolic and cardiac diseases.

Two of her primary collaborators are Jon Klingensmith, PhD, assistant professor in the SIUE School of Engineerings Department of Electrical and Computer Engineering, and Pamela Woodard, PhD, with the Washington University School of Medicine.

Fernandez del Valle is also a research mentor for students, most of whom have earned competitive research awards and Undergraduate Research and Creative Activities accolades.

We can teach in the classroom and explain concepts, but when students are in a lab, I can see their faces and how it just clicks that Oh, now thats what this means and This is connecting with this, she said. Without my collaborators and students assistance, this work would not be possible. It involves human subjects, assessment training and implementation, data reporting and much more.

Before working in this lab, I wasnt sure what I wanted to do post-graduation, said graduate student and research assistant Paige Davis. Now, I know I want to work in a research lab at a college or government agency. I love the mix of human interaction and data entry, and how everything comes together to achieve interesting results.

Original post:
Our Education: SIUEs Fernandez del Valle committed to optimizing womens health - Alton Telegraph

660 young scientists invited to 70th anniversary of Lindau Nobel Laureate Meetings – The Medical News

Young scientists from 101 countries are invited to the 70th anniversary of the Lindau Nobel Laureate Meetings. This was the result of the decision taken today by the Council for the Meetings to conclude the nomination and selection process.

"We are pleased to inform you that the scientific review panel of the Meetings has selected you to participate in the 70th Lindau Nobel Laureate Meeting taking place from 28 June to 3 July 2020 in Lindau, Germany." While the "important phone call from Stockholm" usually comes as a complete surprise to freshly selected Nobel Laureates, the young scientists have been waiting for days for this message in their mailbox. - Today the notifications of acceptance are sent from Lindau to the young researchers all over the world.

Countess Bettina Bernadotte, President of the Council: "Every year it is very moving to be able to offer so many excellent students, PhD candidates and post-docs this opportunity for an exchange and for the further development of their careers. For our 70th Meeting we are particularly pleased that we were able to gain new academic partners in four countries who will send Young Scientists to Lindau this summer."

In addition to almost 200 academic partners - academies of science, universities, foundations and research-based companies - once again six Nobel Laureates nominated young scientists for participation. All nominees have gone through a demanding, multi-stage selection process over the past few months: Following the nomination, they had to submit extensive documentation on their previous scientific career as a first step. On this basis a preliminary evaluation took place. For the first time this year, it was supported by Lindau Alumni who had attended the Lindau Meeting themselves in previous years. The final decision was taken by the scientific chairpersons of the 70th Lindau Meeting - this year with an interdisciplinary programme (every five years) professors from three scientific disciplines: Heiner Linke and Wolfgang Lubitz (Chemistry), Klas Krre and Stefan Kaufmann (Physiology or Medicine) as well as Lars Bergstrm and Rainer Blatt (Physics).

Young scientists around the globe interested in participating in future Lindau Nobel Laureate Meetings can obtain information here: http://www.lindau-nobel.org/application-faq (application procedure from September 2020) The 71st Lindau Nobel Laureate Meeting from 27 June - 2 July 2021 will be dedicated to chemistry by rota.

These young scientists will attend the 70th Lindau Nobel Laureate Meeting

- 660 researchers from 101 countries

- 45% female, 54% male, 1% no comment

- youngest participants: 18 years

- Disciplines: 34% Chemistry, 16% Physiology or Medicine, 21% Biology, 29% Physics

Go here to read the rest:
660 young scientists invited to 70th anniversary of Lindau Nobel Laureate Meetings - The Medical News